Video game therapy shows promise for kids with ADHD
NCT ID NCT07173439
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested a digital therapeutic device that combines driving simulations and memory exercises to improve attention and reduce hyperactivity in children with ADHD. About 120 children aged 6 to 12 took part, with some using the active device and others a placebo version. The goal was to see if this non-drug approach could safely ease core ADHD symptoms.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- digital therapeutic device (driving simulation and N-Back cognitive training)
- What this could lead to
- If it works, this could offer a drug-free option to help children with ADHD improve attention and reduce hyperactivity.
- What could go wrong
- This is a single completed trial with 120 participants, so results may not apply to all children. The placebo also included a driving simulation, which may reduce the apparent benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
120 people
The number who actually took part.
- Started
-
Apr 2024
- Finished
-
May 2025
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
6 to 12 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Subjects must meet all the following inclusion criteria: * Children and adolescents aged 6 years or older but under 13 years, both male and female. * Diagnosed with ADHD according to DSM-5 criteria or ICD-10 diagnosis of ADHD (F90.0). * K-ARS scores of 18 or higher for females and 22 or higher for males. * No changes in ADHD medication dosage or regimen within 1 month prior to enrollment (\*For those receiving pharmacological treatment with methylphenidate or amphetamine-based products, a washout period of 14 days is required if they wish to participate after discontinuing medication). * Medically healthy based on medical history and vital signs assessed during screening, without other medical abnormalities. * Able to use a smartphone or tablet PC that meets specified requirements to operate the mobile application without difficulty. * Both the subject and their guardian voluntarily agree to participate and provide written informed consent. Exclusion Criteria: * Subjects will be excluded if they meet any of the following criteria: * Presence of any of the following psychiatric symptoms at baseline: chronic tic disorder (requiring medication), Tourette's disorder, or history of major obsessive-compulsive disorder, schizophrenia, bipolar disorder, post-traumatic stress disorder, conduct disorder, or other childhood psychosis (affective disorders are not exclusionary). * Wechsler Intelligence Scale for Children (WISC) score below 80. * Presence of congenital genetic disorders. * Uncontrolled or severe systemic physical illness requiring hospitalization at baseline. * Suicide attempt within the past 3 months and assessed as high suicide risk by a psychiatrist. * Initiation or ongoing other cognitive behavioral therapy within the past 3 months (including any CBT for ADHD or other conditions, based on insurance coverage). * Presence of visual, auditory, or cognitive impairments. * Any other reasons deemed by the investigator to make the subject unsuitable for participation in the clinical trial.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADHD are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Emotiv
Seoul, gangnam, 06179, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can treating Mom's ADHD help her Child's symptoms?
- Can meal timing reset ADHD symptoms and sleep?
- Can a personalized mix of nerve stimulation and therapy rewire the brain for better mental health?
- Scientists map the hidden effort strategies behind ADHD
- Can a computer help pick the right ADHD medicine for your child?
- Can hormone cycles explain ADHD symptoms in teen girls?